Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations
The Journal of Physical Chemistry B · 2025
DOI: 10.1021/acs.jpcb.5c01781 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2025. Verfasst von Juan Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Guangdong Medical University, Dongguan 523808, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Molecular Dynamics Simulation, Antineoplastic Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science Fund for Distinguished Young Scholars of Guangdong Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Guangdong Medical University, Dongguan 523808, China.
- State-province Joint Engineering Laboratory of Targeted Drugs from Natural Products, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
- Shanghai Engineering Research Center of Molecular herapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.
- Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen 361003, China.
- State Key Laboratory of Porous Materials for Separation and Conversion, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, MOE Key Laboratory of Computational Physical Sciences, Department of Chemi…
ORCID-Profile: Juan Zeng, Fei Xia, Xianming Deng, Xin Xu
Förderung
- National Key Research and Development Program of China
- Science Fund for Distinguished Young Scholars of Guangdong Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zeng, J., Li, L., Sun, C., Sheng, S., Tan, Y., Chen, J., Xia, F., Deng, X., & Xu, X. (2025). Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c01781
Vancouver
Zeng J, Li L, Sun C, Sheng S, Tan Y, Chen J, et al. Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations. The Journal of Physical Chemistry B. 2025. doi:10.1021/acs.jpcb.5c01781
BibTeX
@article{Zeng2025,
author = {Zeng, Juan and Li, Li and Sun, Chi and Sheng, Shen and Tan, Yuhua and Chen, Jian and Xia, Fei and Deng, Xianming and Xu, Xin},
title = {Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations},
journal = {The Journal of Physical Chemistry B},
year = {2025},
doi = {10.1021/acs.jpcb.5c01781}
}
EUVIMED